Absence of steroid biosynthetic defects in heterozygote individuals for classic 11{beta}-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene
- Hadassah-Hebrew Univ. Medical Center, Jerusalem (Israel)
Steroid 11{beta}-hydroxylase deficiency (failure to convert 11-deoxycortisol to cortisol) is responsible for less than 5% of cases of classic congenital adrenal hyperplasia, but it is relatively frequent in Israel, among Jews of Moroccan origin. Affected individuals have a single base substitution in exon 8 of CYP11B1 gene, codon 448, from CGC (arginine) to CAC (histidine) (R448H), a mutation that abolishes enzyme activity completely. We studied the hormonal response to ACTH stimulation in individuals genotyped to have the R448H mutation in one allele only (heterozygotes), and who were therefore assumed to have 50% of 11{beta}-hydroxylase activity. No demonstrable hormonal abnormalities were found in the 6 adults (3 mothers and 3 fathers) and 2 sons studied, suggesting that a quantitatively reduced 11{beta}-hydroxylase is still enough for normal adrenal biosynthesis. 19 refs., 1 fig., 2 tabs.
- OSTI ID:
- 391047
- Journal Information:
- Journal of Clinical Endocrinology and Metabolism, Vol. 80, Issue 12; Other Information: PBD: Dec 1995
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cloning of cDNA encoding steroid 11. beta. -hydroxylase (P450c11)
Role of steroid 11. beta. -hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans